- Trials with a EudraCT protocol (718)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (12)
718 result(s) found for: alopecia.
Displaying page 1 of 36.
EudraCT Number: 2020-000113-33 | Sponsor Protocol Number: IM011-134 | Start Date*: 2023-02-14 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study to Evaluate Clinical Efficacy and Safety of Deucravacitinib (BMS-986165) in Participants with Alopecia Ar... | |||||||||||||
Medical condition: Alopecia Areata | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002365-18 | Sponsor Protocol Number: CP543.5002 | Start Date*: 2021-12-06 | |||||||||||
Sponsor Name:Sun Pharmaceutical Industries, Inc. | |||||||||||||
Full Title: A MULTICENTER, OPEN-LABEL, EXTENSION STUDY TO ASSESS THE LONG-TERM SAFETY AND EFFICACY OF CTP-543 IN ADULT PATIENTS WITH MODERATE TO SEVERE ALOPECIA AREATA | |||||||||||||
Medical condition: MODERATE TO SEVERE ALOPECIA AREATA IN ADULT PATIENTS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Ongoing) HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-018109-29 | Sponsor Protocol Number: MINALO3004 | Start Date*: 2010-07-05 | |||||||||||
Sponsor Name:Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. | |||||||||||||
Full Title: A PHASE 3 MULTI-CENTER PARALLEL DESIGN CLINICAL TRIAL TO COMPARE THE EFFICACY AND SAFETY OF 5% MINOXIDIL FOAM VS. 2% MINOXIDIL SOLUTION IN FEMALES FOR THE TREATMENT OF FEMALE PATTERN HAIR LOSS (AND... | |||||||||||||
Medical condition: FEMALE PATTERN HAIR LOSS (ANDROGENETIC ALOPECIA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019881-96 | Sponsor Protocol Number: MINALO3005 | Start Date*: 2010-11-19 | |||||||||||
Sponsor Name:Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. | |||||||||||||
Full Title: A PHASE 3 MULTI-CENTER PARALLEL DESIGN CLINICAL TRIAL TO COMPARE THE EFFICACY AND SAFETY OF 5% MINOXIDIL FOAM VS. VEHICLE IN FEMALES FOR THE TREATMENT OF FEMALE PATTERN HAIR LOSS (ANDROGENETIC ALOP... | |||||||||||||
Medical condition: FEMALE PATTERN HAIR LOSS (ANDROGENETIC ALOPECIA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002704-40 | Sponsor Protocol Number: CP543.3001 | Start Date*: 2021-03-26 | |||||||||||
Sponsor Name:Concert Pharmaceuticals, Inc | |||||||||||||
Full Title: A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CTP- 543 in Adult Patients with Moderate to Severe Alopecia Areata | |||||||||||||
Medical condition: Moderate to severe alopecia areata in adult patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018291-25 | Sponsor Protocol Number: CRC-AGA02 | Start Date*: 2010-08-25 | |||||||||||
Sponsor Name:Charité-Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie, CRC | |||||||||||||
Full Title: INVESTIGATOR-INITIATED, DOUBLE BLIND, TWO-ARMED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL WITH AN OPEN-LABEL EXTENSION PHASE, TO INVESTIGATE EFFICACY OF 5% MINOXIDIL TOPICAL FOAM TWICE DAILY I... | |||||||||||||
Medical condition: Otherwise healthy men with androgenetic alopecia (Hamilton-Norwood Scale IIIvertex to VI) in the temple and vertex area. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004130-15 | Sponsor Protocol Number: CRC-AGA-M-A-11 | Start Date*: 2014-06-03 | |||||||||||
Sponsor Name:Charité-Universitätsmedizin Berlin, Department of Dermatology, Clinical Research Center for Hair and Skin Science | |||||||||||||
Full Title: Investigator-initiated clinical research trial on the effects of 5% Minoxidil topical foam on gene expression, hair growth and scalp microenvironment in men with androgenetic alopecia | |||||||||||||
Medical condition: Androgenetic Alopecia Hamilton-Norwood IIIv-IV male patients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003733-23 | Sponsor Protocol Number: CB-03-01/34 | Start Date*: 2017-05-09 | |||||||||||
Sponsor Name:Cassiopea S.p.A. | |||||||||||||
Full Title: A PHASE 2, MULTICENTER, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CB 03 01 (CORTEXOLONE 17α-PROPIONATE) SOLUTION FOR THE... | |||||||||||||
Medical condition: AGA (androgenic alopecia) is scalp hair loss that occurs due to an underlying susceptibility of hair follicles to androgenic miniaturization. In the hair follicle, testosterone is converted by 5α-... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001509-21 | Sponsor Protocol Number: B7981037 | Start Date*: 2020-12-08 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A PHASE 2a, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE SAFETY OF RITLECITINIB (PF 06651600) IN ADULT PARTICIPANTS WITH ALOPECIA AREATA | |||||||||||||
Medical condition: Alopecia areata | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000659-18 | Sponsor Protocol Number: FumadermAA01 | Start Date*: 2011-08-22 | |||||||||||
Sponsor Name:University Hospital Tübingen | |||||||||||||
Full Title: Treatment of therapy resistant Alopecia areata with fumaric acid esters (Fumaderm® and Fumaderm initial®) – an open, single center, non-randomized, pilot study with 40 patients | |||||||||||||
Medical condition: Alopecia areata | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003809-17 | Sponsor Protocol Number: FCS-002 | Start Date*: 2018-01-04 | |||||||||||
Sponsor Name:Follicum AB | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled phase 2 trial of FOL-005 to investigate efficacy on hair growth on scalp skin in healthy volunteers. | |||||||||||||
Medical condition: Alopecia. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-018191-34 | Sponsor Protocol Number: FOL003 | Start Date*: 2010-07-21 | |||||||||||
Sponsor Name:Follica Inc. | |||||||||||||
Full Title: A Study to Explore the Effect of Controlled Cutaneous Perturbation and Pharmacologic Modulation for Inducing Follicular Neogenesis | |||||||||||||
Medical condition: Male subjects with androgenetic alopecia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002877-40 | Sponsor Protocol Number: PM1541 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Polichem S.A. | |||||||||||||
Full Title: A multicentre, randomized, double-blind, parallel-group, controlled study, to assess the efficacy and safety of P-3074 cutaneous spray, solution, in the treatment of male pattern baldness. | |||||||||||||
Medical condition: Androgenetic alopecia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) BE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000387-30 | Sponsor Protocol Number: CP543.3002 | Start Date*: 2021-06-11 | |||||||||||
Sponsor Name:Concert Pharmaceuticals, Inc. | |||||||||||||
Full Title: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CTP-543 IN ADULT PATIENTS WITH MODERATE TO SEVERE ALOPECIA AREATA | |||||||||||||
Medical condition: MODERATE TO SEVERE ALOPECIA AREATA IN ADULT PATIENTS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) HU (Completed) ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000950-78 | Sponsor Protocol Number: CB-03-01/35 | Start Date*: 2019-08-20 | |||||||||||
Sponsor Name:Cassiopea S.p.A. | |||||||||||||
Full Title: A Phase 2, multicenter, prospective, randomized, double-blind, Minoxidil and vehicle controlled, dose-ranging study to evaluate the efficacy and safety of CB-03-01 (Cortexolone 17α-propionate) solu... | |||||||||||||
Medical condition: Female Androgenic Alopecia (AGA) is scalp hair loss that occurs due to an underlying susceptibility of hair follicles to androgenic miniaturization. In the hair follicle, testosterone is converted ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001705-42 | Sponsor Protocol Number: CRB-MNX-08-01 | Start Date*: 2008-06-04 | |||||||||||
Sponsor Name:L'OREAL | |||||||||||||
Full Title: ETUDE TRANSCRIPTOMIQUE DE LA REPONSE AU MINOXIDIL CHEZ L'HOMME ALOPECIQUE | |||||||||||||
Medical condition: alopécie androgénétique | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000379-15 | Sponsor Protocol Number: 192024-057 Amendment 2 | Start Date*: 2011-06-21 | |||||||||||
Sponsor Name:Allergan Ltd. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety and Efficacy of Bimatoprost Solution 0.03%, 0.1%, and 0.3% Compared with Vehicle in Men with Androgenic Alopecia... | |||||||||||||
Medical condition: Androgenic alopecia in men | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003208-30 | Sponsor Protocol Number: RAAINBOW | Start Date*: 2017-11-14 |
Sponsor Name:Legacy Healthcare (France) SAS | ||
Full Title: Double-blind, vehicle-controlled, randomised, multi-centre study to evaluate the efficacy and safety of LH-8 cutaneous solution in children and adolescents with moderate to severe scalp alopecia ar... | ||
Medical condition: Alopecia Areata | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Ongoing) BG (Completed) FR (Completed) RO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000511-28 | Sponsor Protocol Number: NEOSH101-CLIN-AGA004 | Start Date*: 2007-04-20 | |||||||||||
Sponsor Name:Neosil Inc. | |||||||||||||
Full Title: A Phase 2 Multicenter, Randomized, Placebo-Controlled, Double-Blind Parallel Group Dose-Ranging Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alopec... | |||||||||||||
Medical condition: The study will be performed in male subjects with androgenetic alopecia, Norwood-Hamilton grades III - IV. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002757-72 | Sponsor Protocol Number: NEOSH101-CLIN-AGA003 | Start Date*: 2006-11-30 | |||||||||||
Sponsor Name:Neosil Inc. | |||||||||||||
Full Title: A Phase 2 Multicenter, Randomized, Placebo- and Comparator Controlled, Double-Blind Parallel Group Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alo... | |||||||||||||
Medical condition: The study will be performed in male subjects with androgenetic alopecia, Norwood -Hamilton grades III - IV. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
